Here are five things to know:
1. The products were developed by CareFusion, a global medical technology corporation serving the healthcare industry, which was taken over by BD in March 2015.
2. The products are 13-gauge AVAmax VBS and 11-gauge AVAflex VBS.
3. The spine augmentation devices are designed to reduce and stabilize spinal fractures and consequently offer instant and extended respite from pain.
4. The balloon of the new 13-gauge AVAmax VBS will be the smallest straight-line vertebral balloon, available in lengths of 10mm, 15mm and 20mm, while the 11-gauge AVAflex VBS will be the smallest curved balloon in the market with the advantage of a smaller access point.
5. According to a research report by MarketsandMarkets, the global spinal implants and spinal devices market is projected to a reach a valuation of nearly $15.73 billion by 2020.
More articles on devices and implants:
FDA gives thumbs-up to 2 new Infuse spine surgery indications — 5 things to know
Google and Johnson & Johnson to form new surgical company — 4 highlights
NuVasive to open new location in Ohio — 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
